NASDAQ:AXLA
Delisted
Axcella Health Inc. Stock News
$0.401
+0 (+0%)
At Close: Mar 28, 2024
3 Pharma Stocks to Dump Before the Damage Is Done
08:00am, Sunday, 08'th Oct 2023
Pharma stocks and the biotech sector can offer explosive gains. It also offers incredibly crushing defeats in which share prices decline precipitously.
Beware! 3 Biotech Stocks Waving Massive Red Flags Right Now
11:28am, Wednesday, 20'th Sep 2023
The biotech sector never fails to offer up stocks full of massive issues at any given time. Developing novel therapeutic devices and pharmaceuticals is, after all, very expensive.
Are Medical Stocks Lagging Axcella Health (AXLA) This Year?
11:17am, Friday, 15'th Sep 2023
Here is how Axcella Health Inc. (AXLA) and Clover Health Investments, Corp. (CLOV) have performed compared to their sector so far this year.
Why Is Axcella Health (AXLA) Stock Down 24% Today?
09:01am, Friday, 15'th Sep 2023
Axcella Health (NASDAQ: AXLA ) stock is taking a beating on Friday after the biotechnology company announced plans for a reverse stock split. According to Axcella Health, shares of AXLA stock are goi
Why Is Axcella Health (AXLA) Stock Down 21% Today?
09:05am, Thursday, 31'st Aug 2023
Axcella Health (NASDAQ: AXLA ) stock is falling on Thursday following its announcement of a new Covid-19 treatment patent. However, it's not that this is bad news for the clinical-stage biotechnology
Axcella (AXLA) Up on Patent Grant for Long Covid Fatigue Drug
10:31am, Wednesday, 30'th Aug 2023
Axcella (AXLA) shares surge 299% after the company secures a methods-of-use patent for its lead candidate, AXA1125, which is currently under development to treat fatigue associated with Long Covid.
Why Is Axcella Health (AXLA) Stock Up 280% Today?
01:19pm, Tuesday, 29'th Aug 2023
A little-known penny stock is among the market's top movers today. Axcella Health (NASDAQ: AXLA ) stock surged by as much as 280% on news that it has been granted an important new patent.
Axcella Health stock rockets on long Covid patent win
09:28am, Tuesday, 29'th Aug 2023
Axcella Health Inc (NASDAQ:AXLA) saw its stock rocket some 240% higher in Tuesday's early deals after the small-cap firm announced it had secured a patent for its treatment for ‘long' Covid fatigue.
Why Is Axcella Health (AXLA) Stock Up 68% Today?
08:04am, Tuesday, 22'nd Aug 2023
Axcella Health (NASDAQ: AXLA ) stock is rocketing higher on Tuesday despite a lack of news from the clinical-stage biotechnology company. There are no new press releases or filings with the Securitie
Why Is Axcella Health (AXLA) Stock Up 35% Today?
07:35am, Thursday, 16'th Feb 2023
Axcella Health (NASDAQ: AXLA ) stock is on the rise Wednesday as investors react to an update from the FDA. That update has to do with the company's Long Covid Fatigue treatment currently in develop
Penny Stocks To Buy Now? 7 To Watch With Big News this Week
09:28am, Thursday, 26'th Jan 2023
Penny stocks with news that has turned heads in the stock market this week. The post Penny Stocks To Buy Now?
4 Penny Stocks To Watch With Big News This Week
12:10pm, Wednesday, 25'th Jan 2023
Penny stocks to watch after big news this week. The post 4 Penny Stocks To Watch With Big News This Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Why Is Axcella Health (AXLA) Stock Up 66% Today?
08:06am, Tuesday, 24'th Jan 2023
Axcella Health (NASDAQ: AXLA ) stock is rocketing higher on Tuesday after revealing a regulatory path to registration for AXA1125. Investors will note that AXA1125 is the company's treatment for Long
How to Find Undervalued Penny Stocks: Quick Guide
06:00am, Tuesday, 20'th Dec 2022
Use these tools to find cheap penny stocks to buy The post How to Find Undervalued Penny Stocks: Quick Guide appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Axcella Health Inc. (AXLA) Loses 47.9% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
11:18am, Friday, 11'th Nov 2022
Axcella Health Inc. (AXLA) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings